Home Tools
Log in
Cart

Search Result

Search Results for " 2-ag "

20

Compounds

Cat No. Product Name Synonyms Targets
T4694 AG-1557 hydrochloride (189290-58-2(free base)) EGFR , HER
AG-1557 hydrochloride is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
T6266 PP2 AGL 1879,AG 1879,AGL 1879 EGFR , Tyrosine Kinases , JAK , Src
PP2 (AG 1879,AGL 1879) is a effective inhibitor of Lck/Fyn (IC50:4/5 nM) , ~100-fold less potent to EGFR, inactive for ZAP-70, PKA and JAK2.
T7493 AG-13958 AG-013958 VEGFR
AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration.
T1088 Repaglinide AG-EE 388 ZW,AG-EE 623ZW Potassium Channel , PPAR
Repaglinide (AG-EE 623ZW) is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically appare...
T13238 Tyrphostin AG1433 SU1433,AG1433 VEGFR , PDGFR
Tyrphostin AG1433 (AG1433) is an inhibitor of tyrosine kinases and also a dual inhibitor of PDGFRβ(IC50s = 5.0 μM) and VEGFR-2 (Flk-1/KDR)(IC50s = 9.3 μM).
T22253 AG-120 (racemic) Dehydrogenase
AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
T4052 KML29 Lipase
KML29 is highly selective and effective monoacylglycerol lipase (MAGL) inhibitor. It has effective inhibition of human/mouse/rat MAGL (IC50: 5.9/15/43 nM). It has not inhibitory for FAAH (IC50 > 50 μM). It also effective...
T29372 2-Pyridineacetamide, 5-ethylthio- AG-41,AG 41,AG41
2-Pyridineacetamide, 5-ethylthio- is a biochemical.
T29373 2-Pyridineacetamide, 5-methylthio- AG 42,AG-42 AG42
2-Pyridineacetamide, 5-methylthio- is a biochemical.
T22456 Voreloxin hydrochloride SNS-595 hydrochloride,Vosaroxin Apoptosis , Topoisomerase
Voreloxin hydrochloride (SNS-595 hydrochloride) is a potent inhibitor of Topoisomerase II with broad-spectrum anti-tumor activity.
T4554 AG 1406 VEGFR
AG 1406 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2.
T2346 Enasidenib AG-221 Dehydrogenase , Isocitrate Dehydrogenase (IDH)
Enasidenib (AG-221) is an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity.
T11724 JNJ-42226314 Lipase
JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.JNJ-42226314 shows efficacy via endogenous cannabinoid-2-acryloylglycerol (2-AG) in models of neuropathic ...
T14137 AG 1295 PDGFR
AG 1295, a selective inhibitor of platelet-derived growth factor receptor (PDGFR) tyrosine-kinase, effectively halts PDGFR autophosphorylation without impacting the autophosphorylation of the EGF receptor[1][2][3][4].
T4205 AG-494 Tyrphostin AG-494,AG 494,Tyrphostin B48 EGFR , CDK
AG-494 (Tyrphostin B48) is an inhibitor of epidermal growth factor receptor kinase.
T1452 Axitinib AG-013736 VEGFR , PDGFR , c-Kit
Axitinib (AG-013736) is an orally bioavailable tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.7, 1.6 nM for VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFRβ, respectively.
T3617 Ivosidenib AG-120 Dehydrogenase , Isocitrate Dehydrogenase (IDH)
Ivosidenib (AG-120) is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity. Ivosidenib specifically inhibits a mutated form of IDH1 in the cytoplasm, which inhi...
T4092 AG126 Tyrphostin AG126,AG 126 ERK , COX
AG126 (Tyrphostin AG126) selectively inhibits the phosphorylation of ERK1 (p44) and ERK2 (p42) at 25-50 μM. It blocks the production of TNF-α in vitro2 and in vivo, attenuating signaling through NF-κB, the induced expres...
T6554 JZL 184 JZL184 Lipase
JZL 184 is a potent and selective inhibitor of MAGL with IC50 of 8 nM and 4 μM for inhibition of MAGL and FAAH in mouse brain membranes respectively.
T5815 MJN110 Cravatt Reagent Lipase
MJN110 (Cravatt Reagent) is a potent and selective MAGL inhibitor. Cravatt Reagent inhibits MAGL (IC50 = 9.1 nM). MJN110(Cravatt Reagent) Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
1 2
TargetMol